Article (Scientific journals)
The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action.
Ethgen, Olivier; Beaudart, Charlotte; Buckinx, Fanny et al.
2017In Calcified Tissue International, 100 (3), p. 229-234
Peer Reviewed verified by ORBi
 

Files


Full Text
The Future Prevalence of Sarcopenia in Europe - A Claim for Public Health Action.pdf
Publisher postprint (704.55 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Burden of disease; Prevalence; Public health; Sarcopenia
Abstract :
[en] Sarcopenia is a major public health issue. To convince health policy makers of the emergency to invest in the sarcopenia field, it is of critical importance to produce reliable figures of the expected burden of sarcopenia in the coming years. Age- and gender-specific population projections were retrieved until 2045 from the Eurostat online database (28 European countries). Age- and gender-specific prevalences of sarcopenia were interpolated from a study that compared prevalence estimates according to the different diagnostic cutoffs of the EWGSOP proposed definition. The reported prevalence estimates were interpolated between 65 and 100 years. Interpolated age- and gender-specific estimates of sarcopenia prevalence were then applied to population projections until 2045. Using the definition providing the lowest prevalence estimates, the number of individuals with sarcopenia would rise in Europe from 10,869,527 in 2016 to 18,735,173 in 2045 (a 72.4% increase). This corresponds to an overall prevalence of sarcopenia in the elderly rising from 11.1% in 2016 to 12.9% in 2045. With the definition providing the highest prevalence estimates, the number of individuals with sarcopenia would rise from 19,740,527 in 2016 to 32,338,990 in 2045 (a 63.8% increase), corresponding to overall prevalence rates in the elderly of 20.2% and 22.3% for 2016 and 2045, respectively. We showed that the number of sarcopenic patients will dramatically increase in the next 30 years, making consequences of muscle wasting a major public health issue.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Ethgen, Olivier ;  Université de Liège > Département des sciences de la santé publique > Santé publique : aspects spécifiques
Beaudart, Charlotte ;  Université de Liège > Département des sciences de la santé publique > Epidémiologie clinique
Buckinx, Fanny  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action.
Publication date :
March 2017
Journal title :
Calcified Tissue International
ISSN :
0171-967X
eISSN :
1432-0827
Publisher :
Springer, Germany
Volume :
100
Issue :
3
Pages :
229-234
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 21 April 2017

Statistics


Number of views
103 (16 by ULiège)
Number of downloads
5 (5 by ULiège)

Scopus citations®
 
160
Scopus citations®
without self-citations
146
OpenCitations
 
128

Bibliography


Similar publications



Contact ORBi